Ceretas Completes Ultrasound Device Prototypes, Triggering Final Grant Payment
CTS: $0.920 +2.22% · MC: $67M
Ceretas completed functional prototypes of navigation software and a lift-assist device intended to enable single-operator ultrasound treatment and reduce device costs. The milestone triggered the final payment under its government-backed grant. The company also secured full ownership of its core intellectual property during the quarter and said its IPO fully funded its Phase 2 Alzheimer’s trial. Ceretas reported yesterday that the trial’s first patient had enrolled ahead of its year-end target.

Comments